Jeevan Scientific Technology Limited (BOM:538837)

Verve Therapeutics Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	2.42	5.45	68.34	297.13	32.55
Short-Term Investments	-	-	-	-	29.56
Cash & Short-Term Investments	2.42	5.45	68.34	297.13	62.12
Cash Growth	-55.50%	-92.03%	-77.00%	378.36%	182.83%
Accounts Receivable	159.42	133.8	117.54	76.1	159.33
Other Receivables	15.5	29.84	52.79	70.97	23
Receivables	174.92	163.64	170.33	147.07	187.52
Inventory	16.18	10.9	8.72	20.36	34.56
Prepaid Expenses	-	4.65	4.26	4.96	3.89
Other Current Assets	94.05	62.11	40.24	69.33	50.61
Total Current Assets	287.58	246.73	291.88	538.85	338.7
Property, Plant & Equipment	323.91	239.42	208.41	140.96	158.8
Long-Term Investments	-	0.04	0.04	0.56	-
Other Intangible Assets	68.56	55.34	60.36	49.76	114.95
Long-Term Deferred Tax Assets	9.19	9.11	6.42	-	6.03
Other Long-Term Assets	93.68	128.01	92.12	48.65	41.3
Total Assets	782.91	678.66	659.23	778.79	659.78
Accounts Payable	31.77	21.47	26.56	20.02	32.6
Accrued Expenses	1.37	19.35	16.86	27.42	47.39
Short-Term Debt	-	10.71	12.92	52.46	0.51
Current Portion of Long-Term Debt	34.13	16.62	16.34	30.72	25.25
Current Portion of Leases	15.76	10.58	13.68	-	-
Current Income Taxes Payable	-	-	-	49.04	17.26
Current Unearned Revenue	-	4.98	7.56	8.01	90.62
Other Current Liabilities	37.67	8.37	19.98	35.28	15.03
Total Current Liabilities	120.71	92.08	113.9	222.95	228.65
Long-Term Debt	117.3	80.5	35.14	42.26	77.7
Long-Term Leases	38.6	15.69	22.87	-	-
Long-Term Deferred Tax Liabilities	-	-	-	5	-
Other Long-Term Liabilities	0	-0	0	-	0
Total Liabilities	282.19	192.34	175	272.96	309.55
Common Stock	158.34	154.8	154.8	153.02	153.02
Additional Paid-In Capital	-	203.77	203.77	187.51	187.51
Retained Earnings	-	72.3	85.27	134.92	7.58
Comprehensive Income & Other	341.1	53.41	38.06	30.38	2.12
Total Common Equity	499.44	484.28	481.9	505.83	350.23
Minority Interest	1.28	2.03	2.34	-	-
Shareholders' Equity	500.71	486.31	484.23	505.83	350.23
Total Liabilities & Equity	782.91	678.66	659.23	778.79	659.78
Total Debt	205.8	134.1	100.95	125.44	103.46
Net Cash (Debt)	-203.38	-128.65	-32.61	171.69	-41.34
Net Cash Per Share	-12.68	-8.31	-2.13	11.22	-2.70
Filing Date Shares Outstanding	16.04	15.48	15.48	15.3	15.3
Total Common Shares Outstanding	16.04	15.48	15.48	15.3	15.3
Working Capital	166.87	154.65	177.99	315.91	110.05
Book Value Per Share	31.14	31.28	31.13	33.06	22.89
Tangible Book Value	430.88	428.94	421.54	456.07	235.28
Tangible Book Value Per Share	26.87	27.71	27.23	29.81	15.38
Buildings	-	51.35	45	8.17	8.17
Machinery	-	352.2	296.16	291.28	285.88
Construction In Progress	-	28.12	19.04	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.